LFT Lument Finance Trust | $2.16
| 5/13/2024 | - | Reiterated Rating | Buy -> Buy | $2.50 -> $2.50 | View details for Jonestrading rating of Lument Finance Trust (NYSE:LFT) on 5/13/2024 |
TLSI TriSalus Life Sciences | $4.18
-1.2% | 5/10/2024 | - | Initiated Coverage | Buy | $16.00 | View details for Jonestrading rating of TriSalus Life Sciences (NASDAQ:TLSI) on 5/10/2024 |
GHI Greystone Housing Impact Investors | $11.14
+1.0% | 5/10/2024 | - | Lower Price Target | Buy -> Buy | $20.00 -> $17.50 | View details for Jonestrading rating of Greystone Housing Impact Investors (NYSE:GHI) on 5/10/2024 |
CTO CTO Realty Growth | $16.42
-0.5% | 5/6/2024 | - | Lower Price Target | Buy -> Buy | $21.00 -> $19.00 | View details for Jonestrading rating of CTO Realty Growth (NYSE:CTO) on 5/6/2024 |
MITT AG Mortgage Investment Trust | $7.00
-7.4% | 5/3/2024 | - | Reiterated Rating | Buy -> Buy | $8.00 -> $8.00 | View details for Jonestrading rating of AG Mortgage Investment Trust (NYSE:MITT) on 5/3/2024 |
NLY Annaly Capital Management | $20.50
+0.8% | 4/25/2024 | - | Reiterated Rating | Buy -> Buy | $21.00 -> $21.00 | View details for Jonestrading rating of Annaly Capital Management (NYSE:NLY) on 4/25/2024 |
AGNC AGNC Investment | $9.48
+0.5% | 4/23/2024 | - | Lower Price Target | Buy -> Buy | $10.75 -> $10.25 | View details for Jonestrading rating of AGNC Investment (NASDAQ:AGNC) on 4/23/2024 |
DX Dynex Capital | $12.46
+0.2% | 4/22/2024 | - | Reiterated Rating | Buy -> Buy | $14.00 -> $14.00 | View details for Jonestrading rating of Dynex Capital (NYSE:DX) on 4/22/2024 |
PINE Alpine Income Property Trust | $14.13
+0.6% | 4/19/2024 | - | Lower Price Target | Buy -> Buy | $19.00 -> $18.00 | View details for Jonestrading rating of Alpine Income Property Trust (NYSE:PINE) on 4/19/2024 |
EFC Ellington Financial | $12.70
+0.1% | 4/19/2024 | - | Initiated Coverage | Hold | | View details for Jonestrading rating of Ellington Financial (NYSE:EFC) on 4/19/2024 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. |
RZLT Rezolute | $5.87
-1.3% | 4/18/2024 | - | Initiated Coverage | Buy | $10.00 | View details for Jonestrading rating of Rezolute (NASDAQ:RZLT) on 4/18/2024 |
CGEM Cullinan Therapeutics | $7.67
-1.3% | 4/17/2024 | - | Boost Price Target | Buy -> Buy | $22.00 -> $26.00 | View details for Jonestrading rating of Cullinan Therapeutics (NASDAQ:CGEM) on 4/17/2024 |
ACHV Achieve Life Sciences | $2.55
-2.3% | 4/17/2024 | - | Initiated Coverage | Buy | $20.00 | View details for Jonestrading rating of Achieve Life Sciences (NASDAQ:ACHV) on 4/17/2024 |
JANX Janux Therapeutics | $23.56
-1.9% | 4/16/2024 | - | Initiated Coverage | Buy | $70.00 | View details for Jonestrading rating of Janux Therapeutics (NASDAQ:JANX) on 4/16/2024 |
MNPR Monopar Therapeutics | $40.69
-1.2% | 4/11/2024 | - | Upgrade | Hold -> Buy | $10.00 | View details for Jonestrading rating of Monopar Therapeutics (NASDAQ:MNPR) on 4/11/2024 |
REAX Real Brokerage | $3.88
-1.8% | 4/8/2024 | - | Reiterated Rating | Buy -> Buy | $4.00 | View details for Jonestrading rating of Real Brokerage (NASDAQ:REAX) on 4/8/2024 |
AGNC AGNC Investment | $9.48
+0.5% | 3/22/2024 | - | Initiated Coverage | Buy | $10.75 | View details for Jonestrading rating of AGNC Investment (NASDAQ:AGNC) on 3/22/2024 |
TWO Two Harbors Investments | $9.80
+0.5% | 3/22/2024 | - | Initiated Coverage | Hold | | View details for Jonestrading rating of Two Harbors Investments (NYSE:TWO) on 3/22/2024 |
FEMY Femasys | $0.82
-1.2% | 3/20/2024 | - | Boost Price Target | Buy -> Buy | $7.00 -> $10.00 | View details for Jonestrading rating of Femasys (NASDAQ:FEMY) on 3/20/2024 |
CRNX Crinetics Pharmaceuticals | $27.84
-2.6% | 3/20/2024 | - | Boost Price Target | Buy -> Buy | $52.00 -> $56.00 | View details for Jonestrading rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 3/20/2024 |
GHI Greystone Housing Impact Investors | $11.14
+1.0% | 3/1/2024 | - | Reiterated Rating | Buy -> Buy | $20.00 | View details for Jonestrading rating of Greystone Housing Impact Investors (NYSE:GHI) on 3/1/2024 |
RMAX RE/MAX | $7.54
-2.0% | 3/1/2024 | - | Reiterated Rating | Buy -> Hold | | View details for Jonestrading rating of RE/MAX (NYSE:RMAX) on 3/1/2024 |
RITM Rithm Capital | $12.05
+0.2% | 2/22/2024 | - | Boost Price Target | Buy -> Buy | $11.00 -> $12.00 | View details for Jonestrading rating of Rithm Capital (NYSE:RITM) on 2/22/2024 |
FBRT Franklin BSP Realty Trust | $10.46
+3.6% | 2/16/2024 | - | Lower Price Target | Buy -> Buy | $16.00 -> $15.00 | View details for Jonestrading rating of Franklin BSP Realty Trust (NYSE:FBRT) on 2/16/2024 |
CALC CalciMedica | $2.94
-14.5% | 2/16/2024 | - | Initiated Coverage | Buy | $22.00 | View details for Jonestrading rating of CalciMedica (NASDAQ:CALC) on 2/16/2024 |
PINE Alpine Income Property Trust | $14.13
+0.6% | 2/12/2024 | - | Lower Price Target | Buy -> Buy | $20.00 -> $19.00 | View details for Jonestrading rating of Alpine Income Property Trust (NYSE:PINE) on 2/12/2024 |
NLY Annaly Capital Management | $20.50
+0.8% | 2/8/2024 | - | Boost Price Target | Buy -> Buy | $18.00 -> $21.00 | View details for Jonestrading rating of Annaly Capital Management (NYSE:NLY) on 2/8/2024 |
DX Dynex Capital | $12.46
+0.2% | 1/30/2024 | - | Boost Price Target | Buy -> Buy | $13.00 -> $14.00 | View details for Jonestrading rating of Dynex Capital (NYSE:DX) on 1/30/2024 |
CATX Perspective Therapeutics | $3.68
-4.2% | 11/15/2023 | - | Initiated Coverage | Buy | $14.00 | View details for Jonestrading rating of Perspective Therapeutics (NYSE:CATX) on 11/15/2023 |
DRRX DURECT | $1.84
-1.9% | 11/9/2023 | - | Reiterated Rating | Buy -> Hold | $37.00 | View details for Jonestrading rating of DURECT (NASDAQ:DRRX) on 11/9/2023 |
ARQT Arcutis Biotherapeutics | $14.29
-2.0% | 11/8/2023 | - | Reiterated Rating | Buy -> Hold | | View details for Jonestrading rating of Arcutis Biotherapeutics (NASDAQ:ARQT) on 11/8/2023 |
RMAX RE/MAX | $7.54
-2.0% | 11/3/2023 | - | Lower Price Target | Buy -> Buy | $22.00 -> $18.00 | View details for Jonestrading rating of RE/MAX (NYSE:RMAX) on 11/3/2023 |
CTO CTO Realty Growth | $16.42
-0.5% | 10/30/2023 | - | Lower Price Target | Buy -> Buy | $25.00 -> $21.00 | View details for Jonestrading rating of CTO Realty Growth (NYSE:CTO) on 10/30/2023 |
RITM Rithm Capital | $12.05
+0.2% | 10/27/2023 | - | Upgrade | Hold -> Buy | $11.00 | View details for Jonestrading rating of Rithm Capital (NYSE:RITM) on 10/27/2023 |
REAX Real Brokerage | $3.88
-1.8% | 10/26/2023 | - | Reiterated Rating | Buy -> Buy | $2.50 | View details for Jonestrading rating of Real Brokerage (NASDAQ:REAX) on 10/26/2023 |
DX Dynex Capital | $12.46
+0.2% | 10/24/2023 | - | Lower Price Target | Buy -> Buy | $14.00 -> $13.00 | View details for Jonestrading rating of Dynex Capital (NYSE:DX) on 10/24/2023 |
REAX Real Brokerage | $3.88
-1.8% | 10/6/2023 | - | Initiated Coverage | Buy | $2.50 | View details for Jonestrading rating of Real Brokerage (NASDAQ:REAX) on 10/6/2023 |
CGEM Cullinan Therapeutics | $7.67
-1.3% | 10/6/2023 | - | Initiated Coverage | Buy | $22.00 | View details for Jonestrading rating of Cullinan Therapeutics (NASDAQ:CGEM) on 10/6/2023 |
KZR Kezar Life Sciences | $4.05
-5.2% | 10/5/2023 | - | Reiterated Rating | Buy -> Hold | | View details for Jonestrading rating of Kezar Life Sciences (NASDAQ:KZR) on 10/5/2023 |
FEMY Femasys | $0.82
-1.2% | 9/26/2023 | - | Boost Price Target | Buy -> Buy | $5.00 -> $7.00 | View details for Jonestrading rating of Femasys (NASDAQ:FEMY) on 9/26/2023 |
This New Rule Could Change Everything (Ad) A major change is quietly going into effect this July — and Wall Street is already positioning for it.
Big Banks have found a way to use a new asset as if it were cash.
Not stocks. Not bonds. Not even the U.S. dollar.
They now trust this asset more than the traditional financial system itself. To help you get started, we're giving away a FREE Wealth Protection Guide that shows you exactly how |
PRME Prime Medicine | $4.04
+8.0% | 9/6/2023 | - | Initiated Coverage | Buy | $20.00 | View details for Jonestrading rating of Prime Medicine (NYSE:PRME) on 9/6/2023 |
ACRV Acrivon Therapeutics | $1.26
-1.6% | 8/18/2023 | - | Initiated Coverage | Buy | $26.00 | View details for Jonestrading rating of Acrivon Therapeutics (NASDAQ:ACRV) on 8/18/2023 |
MITT AG Mortgage Investment Trust | $7.00
-7.4% | 8/8/2023 | - | Reiterated Rating | Buy -> Buy | $8.00 | View details for Jonestrading rating of AG Mortgage Investment Trust (NYSE:MITT) on 8/8/2023 |
RMAX RE/MAX | $7.54
-2.0% | 8/4/2023 | - | Reiterated Rating | Buy -> Buy | $22.00 | View details for Jonestrading rating of RE/MAX (NYSE:RMAX) on 8/4/2023 |
NLY Annaly Capital Management | $20.50
+0.8% | 8/3/2023 | - | Reiterated Rating | Buy | $21.00 | View details for Jonestrading rating of Annaly Capital Management (NYSE:NLY) on 8/3/2023 |
KNTK Kinetik | $42.79
-1.4% | 8/2/2023 | - | Initiated Coverage | Buy | $43.00 | View details for Jonestrading rating of Kinetik (NYSE:KNTK) on 8/2/2023 |
FBRT Franklin BSP Realty Trust | $10.46
+3.6% | 8/2/2023 | - | Reiterated Rating | Buy -> Buy | $16.00 | View details for Jonestrading rating of Franklin BSP Realty Trust (NYSE:FBRT) on 8/2/2023 |
MITT AG Mortgage Investment Trust | $7.00
-7.4% | 7/28/2023 | - | Reiterated Rating | Buy | $8.00 | View details for Jonestrading rating of AG Mortgage Investment Trust (NYSE:MITT) on 7/28/2023 |
DX Dynex Capital | $12.46
+0.2% | 7/26/2023 | - | Reiterated Rating | Buy -> Buy | $14.00 | View details for Jonestrading rating of Dynex Capital (NYSE:DX) on 7/26/2023 |
PINE Alpine Income Property Trust | $14.13
+0.6% | 7/21/2023 | - | Reiterated Rating | Buy -> Buy | $24.00 -> $22.00 | View details for Jonestrading rating of Alpine Income Property Trust (NYSE:PINE) on 7/21/2023 |
MITT AG Mortgage Investment Trust | $7.00
-7.4% | 7/13/2023 | - | Reiterated Rating | Buy -> Buy | $8.00 | View details for Jonestrading rating of AG Mortgage Investment Trust (NYSE:MITT) on 7/13/2023 |
ONC Oncolytics Biotech | C$1.37
-2.1% | 5/24/2023 | - | Set Price Target | Buy | C$9.00 | View details for Jonestrading rating of Oncolytics Biotech (TSE:ONC) on 5/24/2023 |
COEP Coeptis Therapeutics | $10.72
+1.1% | 4/19/2023 | - | Initiated Coverage | Buy | $80.00 | View details for Jonestrading rating of Coeptis Therapeutics (NASDAQ:COEP) on 4/19/2023 |
MITT AG Mortgage Investment Trust | $7.00
-7.4% | 4/11/2023 | - | Reiterated Rating | Buy | $8.00 | View details for Jonestrading rating of AG Mortgage Investment Trust (NYSE:MITT) on 4/11/2023 |
FBRT Franklin BSP Realty Trust | $10.46
+3.6% | 4/6/2023 | - | Lower Price Target | Buy | $16.50 -> $16.00 | View details for Jonestrading rating of Franklin BSP Realty Trust (NYSE:FBRT) on 4/6/2023 |
DRRX DURECT | $1.84
-1.9% | 3/14/2023 | - | Initiated Coverage | Buy | $37.00 | View details for Jonestrading rating of DURECT (NASDAQ:DRRX) on 3/14/2023 |
TRVI Trevi Therapeutics | $7.33
-1.1% | 3/14/2023 | - | Initiated Coverage | Buy | $7.00 | View details for Jonestrading rating of Trevi Therapeutics (NASDAQ:TRVI) on 3/14/2023 |
CTO CTO Realty Growth | $16.42
-0.5% | 3/9/2023 | - | Reiterated Rating | Buy | $26.00 | View details for Jonestrading rating of CTO Realty Growth (NYSE:CTO) on 3/9/2023 |
NYMT New York Mortgage Trust | $6.58
+3.9% | 3/1/2023 | - | Reiterated Rating | Buy -> Hold | | View details for Jonestrading rating of New York Mortgage Trust (NASDAQ:NYMT) on 3/1/2023 |
BRSP BrightSpire Capital | $5.17
-0.2% | 3/1/2023 | - | Reiterated Rating | Buy -> Hold | | View details for Jonestrading rating of BrightSpire Capital (NYSE:BRSP) on 3/1/2023 |
PINE Alpine Income Property Trust | $14.13
+0.6% | 2/22/2023 | - | Boost Price Target | Buy | $22.00 -> $24.00 | View details for Jonestrading rating of Alpine Income Property Trust (NYSE:PINE) on 2/22/2023 |
HAFC Hanmi Financial | $22.43
-1.7% | 1/25/2023 | - | Reiterated Rating | Buy | $29.00 | View details for Jonestrading rating of Hanmi Financial (NASDAQ:HAFC) on 1/25/2023 |
GHI Greystone Housing Impact Investors | $11.14
+1.0% | 1/17/2023 | - | Reiterated Rating | Buy | $22.00 | View details for Jonestrading rating of Greystone Housing Impact Investors (NYSE:GHI) on 1/17/2023 |
CTO CTO Realty Growth | $16.42
-0.5% | 1/6/2023 | - | Lower Price Target | Buy | $27.00 -> $26.00 | View details for Jonestrading rating of CTO Realty Growth (NYSE:CTO) on 1/6/2023 |
LFT Lument Finance Trust | $2.16
| 12/19/2022 | - | Lower Price Target | | $3.50 -> $3.00 | View details for Jonestrading rating of Lument Finance Trust (NYSE:LFT) on 12/19/2022 |
MITT AG Mortgage Investment Trust | $7.00
-7.4% | 12/19/2022 | - | Lower Price Target | | $13.00 -> $8.00 | View details for Jonestrading rating of AG Mortgage Investment Trust (NYSE:MITT) on 12/19/2022 |
NYMT New York Mortgage Trust | $6.58
+3.9% | 12/19/2022 | - | Lower Price Target | | $16.00 -> $14.00 | View details for Jonestrading rating of New York Mortgage Trust (NASDAQ:NYMT) on 12/19/2022 |
DX Dynex Capital | $12.46
+0.2% | 12/19/2022 | - | Boost Price Target | | $13.50 -> $14.00 | View details for Jonestrading rating of Dynex Capital (NYSE:DX) on 12/19/2022 |
EARN Ellington Credit | $5.67
-3.1% | 12/19/2022 | - | Initiated Coverage | Hold | | View details for Jonestrading rating of Ellington Credit (NYSE:EARN) on 12/19/2022 |
NLY Annaly Capital Management | $20.50
+0.8% | 12/19/2022 | - | Initiated Coverage | Buy | $22.50 | View details for Jonestrading rating of Annaly Capital Management (NYSE:NLY) on 12/19/2022 |
SACH Sachem Capital | $1.16
| 12/6/2022 | - | Initiated Coverage | Hold | | View details for Jonestrading rating of Sachem Capital (NYSEAMERICAN:SACH) on 12/6/2022 |
BRSP BrightSpire Capital | $5.17
-0.2% | 12/5/2022 | - | Initiated Coverage | Buy | | View details for Jonestrading rating of BrightSpire Capital (NYSE:BRSP) on 12/5/2022 |
AVXL Anavex Life Sciences | $11.20
-0.9% | 12/2/2022 | - | Boost Price Target | | $40.00 -> $80.00 | View details for Jonestrading rating of Anavex Life Sciences (NASDAQ:AVXL) on 12/2/2022 |
DARE Dare Bioscience | $2.42
+0.8% | 11/30/2022 | - | Initiated Coverage | Buy | | View details for Jonestrading rating of Dare Bioscience (NASDAQ:DARE) on 11/30/2022 |
THTX Theratechnologies | $3.16
+0.3% | 11/30/2022 | - | Initiated Coverage | Buy | | View details for Jonestrading rating of Theratechnologies (NASDAQ:THTX) on 11/30/2022 |
PMT PennyMac Mortgage Investment Trust | $11.80
+0.1% | 11/30/2022 | - | Downgrade | Buy -> Hold | | View details for Jonestrading rating of PennyMac Mortgage Investment Trust (NYSE:PMT) on 11/30/2022 |
IKT Inhibikase Therapeutics | $1.52
-3.8% | 11/16/2022 | - | Downgrade | Buy -> Hold | | View details for Jonestrading rating of Inhibikase Therapeutics (NYSE:IKT) on 11/16/2022 |
PINE Alpine Income Property Trust | $14.13
+0.6% | 10/25/2022 | - | Lower Price Target | Buy | $23.00 -> $22.00 | View details for Jonestrading rating of Alpine Income Property Trust (NYSE:PINE) on 10/25/2022 |
LNTH Lantheus | $70.57
-0.9% | 10/6/2022 | - | Initiated Coverage | Buy | $104.00 | View details for Jonestrading rating of Lantheus (NASDAQ:LNTH) on 10/6/2022 |
PSTV Plus Therapeutics | $0.59
+21.1% | 10/6/2022 | - | Initiated Coverage | Buy | $75.00 | View details for Jonestrading rating of Plus Therapeutics (NASDAQ:PSTV) on 10/6/2022 |
RMAX RE/MAX | $7.54
-2.0% | 9/26/2022 | - | Lower Price Target | Buy | $34.00 -> $28.00 | View details for Jonestrading rating of RE/MAX (NYSE:RMAX) on 9/26/2022 |
ARQT Arcutis Biotherapeutics | $14.29
-2.0% | 9/22/2022 | - | Reiterated Rating | Buy | $54.00 | View details for Jonestrading rating of Arcutis Biotherapeutics (NASDAQ:ARQT) on 9/22/2022 |
MDNA Medicenna Therapeutics | C$0.84
| 8/16/2022 | - | Lower Price Target | | C$6.00 -> C$5.00 | View details for Jonestrading rating of Medicenna Therapeutics (TSE:MDNA) on 8/16/2022 |
NYMT New York Mortgage Trust | $6.58
+3.9% | 8/4/2022 | - | Lower Price Target | Buy | $17.00 -> $16.00 | View details for Jonestrading rating of New York Mortgage Trust (NASDAQ:NYMT) on 8/4/2022 |
KZR Kezar Life Sciences | $4.05
-5.2% | 6/28/2022 | - | Boost Price Target | | $170.00 -> $200.00 | View details for Jonestrading rating of Kezar Life Sciences (NASDAQ:KZR) on 6/28/2022 |
APS Aptose Biosciences | C$1.68
-1.2% | 6/3/2022 | Soumit Roy | Reiterated Rating | Buy | C$150.00 | View details for Jonestrading rating of Aptose Biosciences (TSE:APS) on 6/3/2022 |
PMT PennyMac Mortgage Investment Trust | $11.80
+0.1% | 5/6/2022 | Jason Stewart | Lower Price Target | | $18.50 -> $18.00 | View details for Jonestrading rating of PennyMac Mortgage Investment Trust (NYSE:PMT) on 5/6/2022 |
CTO CTO Realty Growth | $16.42
-0.5% | 4/29/2022 | - | Boost Price Target | | $25.00 -> $26.67 | View details for Jonestrading rating of CTO Realty Growth (NYSE:CTO) on 4/29/2022 |
DX Dynex Capital | $12.46
+0.2% | 4/28/2022 | - | Lower Price Target | | $20.00 -> $19.00 | View details for Jonestrading rating of Dynex Capital (NYSE:DX) on 4/28/2022 |
CLNE Clean Energy Fuels | $1.97
-3.0% | 4/8/2022 | - | Initiated Coverage | Buy | | View details for Jonestrading rating of Clean Energy Fuels (NASDAQ:CLNE) on 4/8/2022 |
A new rule goes live in July — and the banks are quietly crushing it (Ad) A little-known regulation quietly goes into effect this July.
And it's already being exploited by Wall Street and the Big Banks…
It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash.
Not stocks. Not real estate. And definitely not the U.S. dollar.
We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them. To help you get started, we're giving away a FREE Wealth Protection Guide that shows you exactly how |
FBRT Franklin BSP Realty Trust | $10.46
+3.6% | 4/8/2022 | - | Initiated Coverage | Buy | $17.00 | View details for Jonestrading rating of Franklin BSP Realty Trust (NYSE:FBRT) on 4/8/2022 |
SBTX Silverback Therapeutics | $17.68
-1.1% | 4/1/2022 | - | Downgrade | Buy -> Hold | | View details for Jonestrading rating of Silverback Therapeutics (NASDAQ:SBTX) on 4/1/2022 |
APS Aptose Biosciences | C$1.68
-1.2% | 3/23/2022 | Soumit Roy | Reiterated Rating | Buy | C$240.00 | View details for Jonestrading rating of Aptose Biosciences (TSE:APS) on 3/23/2022 |
RMAX RE/MAX | $7.54
-2.0% | 3/2/2022 | - | Initiated Coverage | Buy | $38.00 | View details for Jonestrading rating of RE/MAX (NYSE:RMAX) on 3/2/2022 |
CTO CTO Realty Growth | $16.42
-0.5% | 2/28/2022 | - | Boost Price Target | Buy | $70.00 -> $75.00 | View details for Jonestrading rating of CTO Realty Growth (NYSE:CTO) on 2/28/2022 |
ORC Orchid Island Capital | $7.02
+0.9% | 2/25/2022 | Jason Stewart | Downgrade | Buy -> Hold | | View details for Jonestrading rating of Orchid Island Capital (NYSE:ORC) on 2/25/2022 |
NYMT New York Mortgage Trust | $6.58
+3.9% | 2/22/2022 | - | Lower Price Target | Buy | $20.00 -> $18.00 | View details for Jonestrading rating of New York Mortgage Trust (NASDAQ:NYMT) on 2/22/2022 |
CTO CTO Realty Growth | $16.42
-0.5% | 2/2/2022 | - | Initiated Coverage | Buy | $23.33 | View details for Jonestrading rating of CTO Realty Growth (NYSE:CTO) on 2/2/2022 |
DX Dynex Capital | $12.46
+0.2% | 2/7/2022 | - | Lower Price Target | Buy | $20.50 -> $20.00 | View details for Jonestrading rating of Dynex Capital (NYSE:DX) on 2/7/2022 |
PINE Alpine Income Property Trust | $14.13
+0.6% | 2/2/2022 | - | Initiated Coverage | Buy | $23.00 | View details for Jonestrading rating of Alpine Income Property Trust (NYSE:PINE) on 2/2/2022 |
HAFC Hanmi Financial | $22.43
-1.7% | 1/26/2022 | - | Boost Price Target | Buy | $24.00 -> $29.00 | View details for Jonestrading rating of Hanmi Financial (NASDAQ:HAFC) on 1/26/2022 |
ORC Orchid Island Capital | $7.02
+0.9% | 1/24/2022 | Jason Stewart | Upgrade | Hold -> Buy | $21.25 | View details for Jonestrading rating of Orchid Island Capital (NYSE:ORC) on 1/24/2022 |
PMT PennyMac Mortgage Investment Trust | $11.80
+0.1% | 1/7/2022 | Jason Stewart | Initiated Coverage | Buy | $20.50 | View details for Jonestrading rating of PennyMac Mortgage Investment Trust (NYSE:PMT) on 1/7/2022 |
BOLT Bolt Biotherapeutics | $5.53
-2.1% | 12/6/2021 | Soumit Roy | Reiterated Rating | Buy | $900.00 | View details for Jonestrading rating of Bolt Biotherapeutics (NASDAQ:BOLT) on 12/6/2021 |
BOLT Bolt Biotherapeutics | $5.53
-2.1% | 11/24/2021 | Soumit Roy | Reiterated Rating | Buy | $900.00 | View details for Jonestrading rating of Bolt Biotherapeutics (NASDAQ:BOLT) on 11/24/2021 |
MITT AG Mortgage Investment Trust | $7.00
-7.4% | 11/19/2021 | - | Lower Price Target | Buy | $16.00 -> $14.50 | View details for Jonestrading rating of AG Mortgage Investment Trust (NYSE:MITT) on 11/19/2021 |
CBIO Crescent Biopharma | $12.00
-3.4% | 11/12/2021 | Soumit Roy | Downgrade | Buy -> Hold | | View details for Jonestrading rating of Crescent Biopharma (NASDAQ:CBIO) on 11/12/2021 |
ARR ARMOUR Residential REIT | $16.39
+0.5% | 10/28/2021 | - | Downgrade | Buy -> Hold | | View details for Jonestrading rating of ARMOUR Residential REIT (NYSE:ARR) on 10/28/2021 |
BOLT Bolt Biotherapeutics | $5.53
-2.1% | 9/24/2021 | Soumit Roy | Initiated Coverage | Buy | $900.00 | View details for Jonestrading rating of Bolt Biotherapeutics (NASDAQ:BOLT) on 9/24/2021 |
SBTX Silverback Therapeutics | $17.68
-1.1% | 9/16/2021 | Soumit Roy | Reiterated Rating | Buy | $50.00 | View details for Jonestrading rating of Silverback Therapeutics (NASDAQ:SBTX) on 9/16/2021 |
CRNX Crinetics Pharmaceuticals | $27.84
-2.6% | 9/16/2021 | Soumit Roy | Reiterated Rating | Buy | $45.00 | View details for Jonestrading rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 9/16/2021 |
ADAP Adaptimmune Therapeutics | $0.08
-0.5% | 9/13/2021 | Soumit Roy | Reiterated Rating | Buy | $15.00 | View details for Jonestrading rating of Adaptimmune Therapeutics (NASDAQ:ADAP) on 9/13/2021 |
CBIO Crescent Biopharma | $12.00
-3.4% | 9/10/2021 | Soumit Roy | Reiterated Rating | Buy | $1,800.00 | View details for Jonestrading rating of Crescent Biopharma (NASDAQ:CBIO) on 9/10/2021 |
ORC Orchid Island Capital | $7.02
+0.9% | 9/10/2021 | - | Upgrade | Sell -> Hold | | View details for Jonestrading rating of Orchid Island Capital (NYSE:ORC) on 9/10/2021 |
ADAP Adaptimmune Therapeutics | $0.08
-0.5% | 9/7/2021 | - | Reiterated Rating | Buy | $15.00 | View details for Jonestrading rating of Adaptimmune Therapeutics (NASDAQ:ADAP) on 9/7/2021 |
SAVA Cassava Sciences | $2.12
+1.0% | 9/3/2021 | Soumit Roy | Reiterated Rating | Buy | $153.57 | View details for Jonestrading rating of Cassava Sciences (NASDAQ:SAVA) on 9/3/2021 |
SAVA Cassava Sciences | $2.12
+1.0% | 8/25/2021 | Soumit Roy | Reiterated Rating | Buy | $153.57 | View details for Jonestrading rating of Cassava Sciences (NASDAQ:SAVA) on 8/25/2021 |
SBTX Silverback Therapeutics | $17.68
-1.1% | 8/24/2021 | - | Reiterated Rating | Buy | $50.00 | View details for Jonestrading rating of Silverback Therapeutics (NASDAQ:SBTX) on 8/24/2021 |
ACET Adicet Bio | $0.67
-2.2% | 8/24/2021 | - | Reiterated Rating | Buy | $33.00 | View details for Jonestrading rating of Adicet Bio (NASDAQ:ACET) on 8/24/2021 |
CLLS Cellectis | $2.95
+17.5% | 8/20/2021 | - | Reiterated Rating | Buy | $30.00 | View details for Jonestrading rating of Cellectis (NASDAQ:CLLS) on 8/20/2021 |
CBIO Crescent Biopharma | $12.00
-3.4% | 8/9/2021 | Soumit Roy | Initiated Coverage | Buy | $1,800.00 | View details for Jonestrading rating of Crescent Biopharma (NASDAQ:CBIO) on 8/9/2021 |
KZR Kezar Life Sciences | $4.05
-5.2% | 7/20/2021 | - | Initiated Coverage | Buy | $140.00 | View details for Jonestrading rating of Kezar Life Sciences (NASDAQ:KZR) on 7/20/2021 |
IKT Inhibikase Therapeutics | $1.52
-3.8% | 7/15/2021 | - | Initiated Coverage | Buy | $72.00 | View details for Jonestrading rating of Inhibikase Therapeutics (NYSE:IKT) on 7/15/2021 |
FEMY Femasys | $0.82
-1.2% | 7/13/2021 | - | Initiated Coverage | Buy | $8.45 | View details for Jonestrading rating of Femasys (NASDAQ:FEMY) on 7/13/2021 |
KRYS Krystal Biotech | $156.98
+2.0% | 7/2/2021 | Lina Kaminski | Reiterated Rating | Buy | $97.00 | View details for Jonestrading rating of Krystal Biotech (NASDAQ:KRYS) on 7/2/2021 |
AVXL Anavex Life Sciences | $11.20
-0.9% | 6/14/2021 | - | Reiterated Rating | Buy | $35.00 | View details for Jonestrading rating of Anavex Life Sciences (NASDAQ:AVXL) on 6/14/2021 |
AM Antero Midstream | $18.53
+1.0% | 6/8/2021 | - | Downgrade | Buy -> Hold | | View details for Jonestrading rating of Antero Midstream (NYSE:AM) on 6/8/2021 |
MITT AG Mortgage Investment Trust | $7.00
-7.4% | 5/25/2021 | - | Initiated Coverage | Buy | $15.00 | View details for Jonestrading rating of AG Mortgage Investment Trust (NYSE:MITT) on 5/25/2021 |
ACET Adicet Bio | $0.67
-2.2% | 5/5/2021 | - | Initiated Coverage | Buy | $33.00 | View details for Jonestrading rating of Adicet Bio (NASDAQ:ACET) on 5/5/2021 |
CRNX Crinetics Pharmaceuticals | $27.84
-2.6% | 5/3/2021 | - | Initiated Coverage | Buy | $42.00 | View details for Jonestrading rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 5/3/2021 |
ACET Adicet Bio | $0.67
-2.2% | 4/29/2021 | - | Initiated Coverage | Buy | $33.00 | View details for Jonestrading rating of Adicet Bio (NASDAQ:ACET) on 4/29/2021 |
ARR ARMOUR Residential REIT | $16.39
+0.5% | 4/23/2021 | - | Boost Price Target | Buy | $55.00 -> $65.00 | View details for Jonestrading rating of ARMOUR Residential REIT (NYSE:ARR) on 4/23/2021 |
RITM Rithm Capital | $12.05
+0.2% | 4/21/2021 | - | Reiterated Rating | Buy -> Hold | | View details for Jonestrading rating of Rithm Capital (NYSE:RITM) on 4/21/2021 |
ORC Orchid Island Capital | $7.02
+0.9% | 4/21/2021 | - | Reiterated Rating | Hold -> Sell | $30.00 -> $23.75 | View details for Jonestrading rating of Orchid Island Capital (NYSE:ORC) on 4/21/2021 |
ORC Orchid Island Capital | $7.02
+0.9% | 4/15/2021 | - | Downgrade | Hold -> Sell | $30.00 -> $23.75 | View details for Jonestrading rating of Orchid Island Capital (NYSE:ORC) on 4/15/2021 |
RITM Rithm Capital | $12.05
+0.2% | 4/15/2021 | - | Downgrade | Buy -> Hold | | View details for Jonestrading rating of Rithm Capital (NYSE:RITM) on 4/15/2021 |
SAVA Cassava Sciences | $2.12
+1.0% | 3/23/2021 | - | Reiterated Rating | Buy | | View details for Jonestrading rating of Cassava Sciences (NASDAQ:SAVA) on 3/23/2021 |
DTIL Precision BioSciences | $4.62
-2.7% | 3/18/2021 | Soumit Roy | Reiterated Rating | Buy | $810.00 | View details for Jonestrading rating of Precision BioSciences (NASDAQ:DTIL) on 3/18/2021 |
SYBX Synlogic | $1.48
-3.9% | 3/18/2021 | - | Initiated Coverage | Buy | $225.00 | View details for Jonestrading rating of Synlogic (NASDAQ:SYBX) on 3/18/2021 |
CRIS Curis | $1.63
-1.8% | 3/17/2021 | - | Boost Price Target | Buy | $280.00 -> $360.00 | View details for Jonestrading rating of Curis (NASDAQ:CRIS) on 3/17/2021 |
A new rule goes live in July — and the banks are quietly crushing it (Ad) A little-known regulation quietly goes into effect this July.
And it's already being exploited by Wall Street and the Big Banks…
It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash.
Not stocks. Not real estate. And definitely not the U.S. dollar.
We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them. To help you get started, we're giving away a FREE Wealth Protection Guide that shows you exactly how |
SAVA Cassava Sciences | $2.12
+1.0% | 3/17/2021 | - | Initiated Coverage | Buy | | View details for Jonestrading rating of Cassava Sciences (NASDAQ:SAVA) on 3/17/2021 |
HAFC Hanmi Financial | $22.43
-1.7% | 3/11/2021 | - | Initiated Coverage | Buy | $24.00 | View details for Jonestrading rating of Hanmi Financial (NASDAQ:HAFC) on 3/11/2021 |
EQ Equillium | $0.71
+81.6% | 3/3/2021 | - | Initiated Coverage | Buy | $14.00 | View details for Jonestrading rating of Equillium (NASDAQ:EQ) on 3/3/2021 |
DTIL Precision BioSciences | $4.62
-2.7% | 2/24/2021 | - | Initiated Coverage | Buy | $810.00 | View details for Jonestrading rating of Precision BioSciences (NASDAQ:DTIL) on 2/24/2021 |
KRYS Krystal Biotech | $156.98
+2.0% | 2/9/2021 | - | Initiated Coverage | Buy | $97.00 | View details for Jonestrading rating of Krystal Biotech (NASDAQ:KRYS) on 2/9/2021 |
DYN Dyne Therapeutics | $10.05
+2.0% | 2/9/2021 | - | Initiated Coverage | Buy | | View details for Jonestrading rating of Dyne Therapeutics (NASDAQ:DYN) on 2/9/2021 |
LFT Lument Finance Trust | $2.16
| 2/5/2021 | - | Initiated Coverage | Buy | $4.50 | View details for Jonestrading rating of Lument Finance Trust (NYSE:LFT) on 2/5/2021 |
DX Dynex Capital | $12.46
+0.2% | 2/5/2021 | - | Boost Price Target | Buy | $18.50 -> $19.00 | View details for Jonestrading rating of Dynex Capital (NYSE:DX) on 2/5/2021 |
PHAT Phathom Pharmaceuticals | $8.35
-2.2% | 1/28/2021 | - | Initiated Coverage | Buy | | View details for Jonestrading rating of Phathom Pharmaceuticals (NASDAQ:PHAT) on 1/28/2021 |
ARQT Arcutis Biotherapeutics | $14.29
-2.0% | 1/28/2021 | - | Initiated Coverage | Buy | | View details for Jonestrading rating of Arcutis Biotherapeutics (NASDAQ:ARQT) on 1/28/2021 |
ORC Orchid Island Capital | $7.02
+0.9% | 1/15/2021 | - | Boost Price Target | Buy | $27.50 -> $30.00 | View details for Jonestrading rating of Orchid Island Capital (NYSE:ORC) on 1/15/2021 |
